Abbott's Antitrust Victory Appealed To Supreme Court

Law360, New York (October 30, 2006, 12:00 AM EST) -- Three months after a federal appeals court dismissed allegations of so-called monopoly leveraging against drug maker Abbott Laboratories Inc., the lead plaintiff in the class action has appealed the decision to the U.S. Supreme Court.

The petition for writ of certiorari, filed Oct. 24 by plaintiffs’ law firm Barnow & Associates PC, seeks to overturn the U.S. Court of Appeals for the Seventh Circuit’s finding that Abbott didn’t violate the Sherman Act when it raised the price of a component of an HIV drug.

The class...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.